Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

During the Trading Day
6.76 +1.00 / +17.36%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.80 +0.04 / +0.59%
 
Volume: 23.8K

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 14.50, with a high estimate of 17.00 and a low estimate of 6.00. The median estimate represents a +114.50% increase from the last price of 6.76.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.37
Sales
$0.00
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.41%
 
 
 
 
 
 
Growthannually -6.02%
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account